Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Watch Trump Orders FTC to Serve AI Companies

Watch Trump Orders FTC to Serve AI Companies

November 10, 2025 Victoria Sterling -Business Editor Business

The Shifting Role of the FTC: from Antitrust ⁢Enforcer to Deal‌ Facilitator

Table of Contents

  • The Shifting Role of the FTC: from Antitrust ⁢Enforcer to Deal‌ Facilitator
    • A Change in Tactics: The FTC Under the ‍Trump Administration
      • Key‍ Takeaways
    • Pfizer ‌and Metsera: A Case Study in FTC Flexibility
    • The Role of AI in Mergers and Acquisitions
      • FTC Merger Review Process – A Simplified Overview
    • Expert Analysis: A Potential Erosion of Antitrust Principles
    • Looking Ahead: The Future of ​FTC Enforcement

November 10, ⁣2025

A Change in Tactics: The FTC Under the ‍Trump Administration

The Federal Trade Commission⁢ (FTC), historically tasked with preventing⁢ monopolies‌ adn⁢ protecting consumers, underwent a⁢ notable shift in strategy ⁢during the Trump administration. Rather than rigorously challenging mergers, the agency ‌appeared to actively facilitate deals, notably in the rapidly evolving landscape⁢ of artificial intelligence and pharmaceutical industries. This change in approach has sparked debate among legal experts and antitrust advocates.

Key‍ Takeaways

  • The FTC, under the Trump administration, appeared to prioritize deal-making over strict antitrust enforcement.
  • This shift was ‌observed in sectors like AI and pharmaceuticals, notably with Pfizer’s acquisition of Metsera.
  • Experts suggest this approach could have long-term implications for market competition and innovation.
  • The⁣ analysis stems from insights provided by Doug Farrar, principal ⁢at Maywood Strategies, and former senior advisor to FTC Commissioner Lina Khan.

Pfizer ‌and Metsera: A Case Study in FTC Flexibility

One prominent ‌example of⁤ this ​altered approach is Pfizer’s takeover of Metsera, an obesity drug maker. While such a merger would have likely⁤ faced ​intense scrutiny in previous administrations, the FTC approved the deal with relatively few conditions. This decision ⁢raised eyebrows, particularly given the growing concentration ​within the pharmaceutical industry and the potential impact on​ drug pricing. The acquisition, finalized in late 2025, allows Pfizer to expand its portfolio of weight-loss treatments, a market projected to reach over $4.1 billion by 2028 (Statista).

The Role of AI in Mergers and Acquisitions

The trend extends beyond pharmaceuticals. ⁢The ‌Trump administration also demonstrated a willingness to approve mergers involving companies⁤ developing artificial intelligence technologies. The rationale, according to sources familiar with the administration’s​ thinking, was to promote American leadership in AI and avoid hindering innovation.Though, critics ⁤argue that this approach could lead to a handful of tech giants dominating the AI landscape, stifling competition and potentially harming consumers.

FTC Merger Review Process – A Simplified Overview

Stage Description Typical timeline
Pre-Merger Notification Companies file a‌ Hart-Scott-Rodino (HSR) Act notification with the FTC and Department of Justice. 30‌ days
Initial Review⁤ (Second Request) FTC/DOJ review the⁣ notification and may issue a “Second​ Request” for more information. 30-60 days (can be extended)
Inquiry ⁢& Analysis Agencies investigate potential antitrust concerns. 6-12 months (or longer)
Resolution agencies can approve, block, or negotiate a settlement (consent decree) with the merging parties. Variable

Expert Analysis: A Potential Erosion of Antitrust Principles

– victoriasterling

The shift ‍in the FTC’s approach under the Trump administration represents a meaningful departure from decades of established antitrust policy.While promoting innovation is ‌a legitimate goal, it should not ‍come at the expense of competition. A‍ concentrated ⁢market, even in a cutting-edge field like AI, ⁣can lead to higher prices, reduced choice, and ultimately, less innovation ‌in‍ the long run. The pfizer-metsera deal, and others like it, warrant ‌careful scrutiny to ensure⁤ that the benefits of these mergers outweigh the potential harms to consumers and the broader economy.

Doug Farrar, currently a principal at ​Maywood Strategies ⁣and previously a ⁤senior advisor to FTC‌ Commissioner Lina Khan, has⁤ been a ⁤vocal critic of this trend. He argues that the FTC’s role is to protect competition, not to facilitate mergers ‍simply because‍ they involve ‍emerging⁢ technologies. Farrar’s insights, shared on November 10th, 2025, highlight the potential⁣ long-term consequences of⁣ prioritizing deal-making over rigorous‍ antitrust enforcement.

Looking Ahead: The Future of ​FTC Enforcement

With a new administration in place,the FTC is ⁤highly likely to return ⁢to a more traditional approach to antitrust enforcement. ​Commissioner Khan,known for her progressive views on antitrust,is expected to prioritize challenging mergers that could harm‍ competition. Though, the legacy‍ of​ the Trump administration’s approach will ‍likely continue to shape the debate over the FTC’s role for years to come. The agency faces ​the challenge of balancing the need ⁢to promote innovation with‌ the imperative to protect consumers and maintain a ⁤competitive​ marketplace.

published November 10, 2025.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Copyright Notice
  • Disclaimer
  • Terms and Conditions

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service